Skip to Content

The originating document has been archived. We cannot confirm the completeness, accuracy and currency of the content.


This page contains information on RECOMBITEK KC2 for veterinary use.
The information provided typically includes the following:
  • RECOMBITEK KC2 Indications
  • Warnings and cautions for RECOMBITEK KC2
  • Direction and dosage information for RECOMBITEK KC2

Recombitek Kc2

This treatment applies to the following species:
Manufacturer: Merial

Canine Parainfluenza-bordetella Bronchiseptica Vaccine

Modified Live Virus, Avirulent Live Culture

For Intranasal Use In Dogs Only


Description And General Information

Recombitek® KC2 is designed to be administered intranasally for convenient, rapid prevention of Canine Upper Respiratory Infection (Kennel Cough). Both of these organisms are widespread, common etiologic agents of this syndrome which appears as a mild, self-limiting disease involving the trachea and bronchi of dogs of any age. It spreads rapidly among dogs that are closely confined as in hospitals, kennels and pet stores. The disease is highly contagious and is transmitted via the airborne route.

Both of the organisms in Recombitek® KC2 are avirulent so that they can be safely administered intranasally with little or no symptoms of disease. By instilling these organisms into the nasal passages, it becomes possible for these agents to infect target cells of the nasalpharyngeal region, mimicking the pathogenesis of natural field infection. A very small percentage of dogs may show sneezing, coughing or nasal discharge for 3-10 days following vaccination. While these are usually temporary symptoms, anti-bacterial therapy may be indicated.

RECOMBITEK KC2 Indications

For the vaccination of healthy, susceptible dogs and puppies as an aid in the prevention of Canine Upper Respiratory Infection (Kennel Cough) caused by canine parainfluenza and Bordetella bronchiseptica. Field studies support the safety of Recombitek® KC2 when administered to puppies as young as 3 weeks of age.


Rehydrate to desired dose volume with accompanying sterile diluent. For five 0.5 mL doses, reconstitute with 2.5 mL of diluent. For five 1 mL doses, reconstitute with 5 mL of diluent. Shake well and use immediately.


Using aseptic technique, administer entire dose intranasally. Use enclosed applicator tip on hub of syringe in place of syringe needle. Apply new nasal applicator tip for each dog vaccinated. Do not vaccinate puppies under 3 weeks of age. Puppies vaccinated between 3 and 6 weeks of age should be revaccinated at 6 weeks of age. Annual revaccination is recommended.


For intranasal use in dogs only; do not vaccinate dogs parenterally. Store out of direct sunlight at a temperature between 35-45°F (2-7°C). Do not freeze. Use entire contents when first opened. Burn containers and all unused contents. Anaphylactoid reactions may occur.





RECOMBITEK is a registered trademark of MERIAL.

Manufactured By Boehringer Ingelheim Vetmedica, Inc., St. Joseph, MO 64506 USA

U.S. Vet. Lic. No. 124

Distributed By MERIAL, INC., Athens, GA 30601, USA



This package contains


1 (5 dose) vial of vaccine, 1 (5 mL) vial of diluent and 5 applicator tips. - Varied Dose Volume, Read Instructions



20 (1 dose) vial of dry vaccine, 20 (1 mL) vials of sterile diluent and 20 nasal applicator tips. - Varied Dose Volume



Nac No.

Telephone:   888-637-4251
Every effort has been made to ensure the accuracy of the RECOMBITEK KC2 information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.

Copyright © 2018 North American Compendiums. Updated: 2018-04-26